2018 Specialty Drug Trends
By: Jason Marcewicz | Content and Communications Specialist | Advanced Medical Strategies
Did you know that in 2018, high dollar specialty drugs accounted for 44 of the total 59 FDA–approved novel drugs? What specialty drugs are on the rise? Which Orphan drugs are the costliest? How can payers evaluate drug views in 2018 and translate them into strategic business outcomes for 2019?
AMS is pleased to continue to inform and educate our members about high dollar pharmaceuticals (and their associated diagnoses), through our annual report on drug trends. You can download the 2018 Specialty Drug Trends report at the link below.